$SOPH
SOPHiA GENETICS SA
CIK:0001840706|SEC Filings
Consolidated Statements of Loss - USD ($) $ in Thousands |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||||
| Profit or loss [abstract] | |||||||
| Revenue | $ 77,271 | $ 65,173 | $ 62,371 | ||||
| Cost of revenue | (25,194) | (21,236) | (19,458) | ||||
| Gross profit | 52,077 | 43,937 | 42,913 | ||||
| Research and development costs | (34,216) | (34,366) | (36,969) | ||||
| Selling and marketing costs | (36,118) | (29,369) | (28,423) | ||||
| General and administrative costs | (52,563) | (46,953) | (53,301) | ||||
| Other operating (loss) income, net | (86) | 183 | 954 | ||||
| Operating loss | (70,906) | (66,568) | (74,826) | ||||
| Interest income | 1,872 | 3,362 | 4,547 | ||||
| Interest expense | (4,554) | (1,913) | (588) | ||||
| Fair value adjustments on warrant obligations | (497) | 370 | [1] | 0 | [1] | ||
| Foreign exchange (losses) gains, net | (3,402) | 3,479 | (7,628) | ||||
| Loss before income taxes | (77,487) | (61,270) | [1] | (78,495) | [1] | ||
| Income tax expense | (1,512) | (1,223) | (486) | ||||
| Loss for the year | (78,999) | (62,493) | (78,981) | ||||
| Attributable to the owners of the parent | $ (78,999) | $ (62,493) | $ (78,981) | ||||
| Earnings per share [abstract] | |||||||
| Basic loss per share (in dollars per share) | $ (1.17) | $ (0.95) | $ (1.22) | ||||
| Diluted loss per share (in dollars per share) | $ (1.17) | $ (0.95) | $ (1.22) | ||||
| |||||||
Consolidated Balance Sheets - USD ($) $ in Thousands |
Dec. 31, 2025 |
Dec. 31, 2024 |
|||
|---|---|---|---|---|---|
| Current assets | |||||
| Cash and cash equivalents | $ 70,289 | $ 80,226 | [1] | ||
| Accounts receivable | 15,001 | 7,436 | |||
| Inventory | 6,351 | 5,868 | |||
| Prepaids and other current assets | 7,438 | 5,875 | |||
| Total current assets | 99,079 | 99,405 | |||
| Non-current assets | |||||
| Property and equipment | 5,665 | 5,209 | |||
| Intangible assets | 35,891 | 28,998 | |||
| Right-of-use assets | 12,382 | 14,168 | |||
| Deferred tax assets | 1,831 | 1,767 | |||
| Other non-current assets | 8,183 | 5,762 | |||
| Total non-current assets | 63,952 | 55,904 | |||
| Total assets | 163,031 | 155,309 | |||
| Current liabilities | |||||
| Accounts payable | 8,960 | 5,220 | |||
| Accrued expenses | 20,736 | 13,217 | |||
| Deferred contract revenue | 16,720 | 5,732 | |||
| Lease liabilities, current portion | 2,700 | 2,190 | |||
| Warrant obligations | 1,412 | 444 | |||
| Total current liabilities | 50,528 | 26,803 | |||
| Non-current liabilities | |||||
| Borrowings | 47,733 | 13,237 | |||
| Lease liabilities, net of current portion | 12,587 | 14,603 | |||
| Defined benefit pension liabilities | 4,162 | 3,839 | |||
| Other non-current liabilities | 876 | 337 | |||
| Total non-current liabilities | 65,358 | 32,016 | |||
| Total liabilities | 115,886 | 58,819 | |||
| Equity | |||||
| Share capital | 4,814 | 4,188 | |||
| Share premium | 473,675 | 472,244 | |||
| Treasury shares | (1,218) | (702) | |||
| Other reserves | 89,150 | 61,037 | |||
| Accumulated deficit | (519,276) | (440,277) | |||
| Total equity | 47,145 | 96,490 | |||
| Total liabilities and equity | $ 163,031 | $ 155,309 | |||
| |||||